-, APL, APL cells, BCL-2, Cdkn1a, E, E-Myc, E-Myc lymphoma, G12D, HDAC, HDAC1, 2, 3, and 6, HDAC1/2, HDAC3, HDACis, HDACs, Hdac1, Hdac2, Hdac3, Hdac3-depleted cells, Hdacs, Histone deacetylase, MLL, MLL-AF9;Nras(G12D); PML-RAR acute promyelocytic leukemia [APL] cells, Nras, PML, RAR, RGFP966, Vorinostat, acute, acute promyelocytic leukemia [APL] cells, belinostat, caspase, class II and, depleted cells, hematological and solid malignancies, hematological malignancies, leukemia and lymphoma, leukemia and lymphoma cells, leukemias, lymphoid and myeloid malignancies, lymphomas, mouse, murine, myeloid leukemias, panobinostat, romidepsin, tumor